arrow
返回

Hemoglobin level variability: Associations with mortality

delete2008-01-01
delete175
delete
OA
AI
D
David T. Gilbertson *
J
James Ebben
R
Robert N. Foley
E
Eric D. Weinhandl
B
Brian D. Bradbury
A
Allan J. Collins
DOI:10.2215/CJN.01610407delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Background/objectives: Awareness of hemoglobin level variability in dialysis patients is increasing, as is interest in its potential implications. In this retrospective, national study of associations between the degree of hemoglobin level variability in the first 6 mo of 2004 and subsequent mortality rates in the following 6 mo, 159,720 hemodialysis patients receiving epoetin therapy were studied. Design, setting, participants, measurements: Monthly hemoglobin values were categorized as low (L; < 11 g/dl), intermediate (I; 11 to 12.5 g/dl), and high ft >12.5 g/dl). Variability groups were classified on the basis of the lowest and highest hemoglobin categories seen during the 6-mo observation period: low-low (L-L), 1.4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I). 18.3%; intermediate-high (I-H), 31.7%. and low-high (L-H), 40.2%. Results: On multivariate analysis, adjusted hazards ratios for subsequent mortality events were as follows: I-I. 1.0 (reference category); I-H, 1.02 (95% confidence interval [CI] 0.95 to 1.11); H-H, 1.06 (95% CI 0.93 to 1.21); L-H, 1.19 (95% CI 1.10 to 1.28); L-I, 1.44 (95% CI 1.33 to 1.56), and L-L, 2.18 (95% CI 1.93 to 2.45). Persistently and transiently low hemoglobin levels and highly variable hemoglobin levels were associated with increased risk of death; transiently and persistently high hemoglobin levels were not associated with increased risk of death. Bayesian modeling indicated that >= 3 mo with hemoglobin levels <11 g/dl may be associated with of increased risk of death. Conclusions: Number of months with hemoglobin values below the target range, rather than hemoglobin variability itself, may be the primary driver of increased risk of death. Further research is needed to distinguish cause from effect and to understand the underlying mechanisms.
Keyword:
CHRONIC KIDNEY-DISEASE
HEMODIALYSIS-PATIENTS
HEMATOCRIT LEVELS
ANEMIA
HOSPITALIZATION
EPOETIN
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Clinical Journal of the American Society of Nephrology 封面图
Clinical Journal of the American Society of Nephrology
IF:
7.1
论文数:
5.7K
被引数:
2.1W

机构

M
minneapolis medical research foundation
学者数:
306
论文数: 292
被引数: 0
引用论文

引用论文

暂无论文信息